Shares of NantHealth Inc (NASDAQ:NH) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $0.60 and last traded at $0.61, with a volume of 2481 shares trading hands. The stock had previously closed at $0.62.

A number of brokerages have issued reports on NH. Zacks Investment Research upgraded shares of NantHealth from a “sell” rating to a “hold” rating in a report on Wednesday, October 17th. BidaskClub downgraded shares of NantHealth from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 21st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. NantHealth presently has an average rating of “Hold” and a consensus target price of $4.08.

The company has a debt-to-equity ratio of 3.89, a quick ratio of 1.23 and a current ratio of 1.24. The firm has a market cap of $68.00 million, a PE ratio of -0.51 and a beta of -0.34.

NantHealth (NASDAQ:NH) last announced its quarterly earnings results on Thursday, November 15th. The company reported ($0.89) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.74). The company had revenue of $22.29 million during the quarter, compared to the consensus estimate of $25.00 million. NantHealth had a negative net margin of 185.22% and a negative return on equity of 116.23%. On average, equities analysts expect that NantHealth Inc will post -1.44 EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. increased its holdings in shares of NantHealth by 9.0% in the 2nd quarter. BlackRock Inc. now owns 2,337,249 shares of the company’s stock worth $7,735,000 after buying an additional 193,491 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of NantHealth by 41.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 120,348 shares of the company’s stock worth $398,000 after buying an additional 35,445 shares during the last quarter. Finally, Vanguard Group Inc increased its holdings in shares of NantHealth by 2.3% in the 3rd quarter. Vanguard Group Inc now owns 646,248 shares of the company’s stock worth $1,015,000 after buying an additional 14,515 shares during the last quarter. Institutional investors own 5.23% of the company’s stock.

WARNING: “NantHealth (NH) Reaches New 1-Year Low at $0.60” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2018/12/18/nanthealth-nh-reaches-new-1-year-low-at-0-60.html.

About NantHealth (NASDAQ:NH)

NantHealth, Inc, together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care.

Featured Story: Conference Calls

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.